Recent studies revealed that Floratek’s new chemical entities exhibited picomolar activity in cancer cells

December 12, 2023

After meticulous SAR refinement through multiple rounds of chemical modifications the new generation of … Read more

Floratek Pharma is ranking 3rd in the most innovative Pharma SME in Switzerland

December 12, 2023

The recent innovation study was carried out by Swiss Institute for Quality Testing (SIQT), … Read more

Thrilled to announce new and very promising results

December 12, 2023

Floratek’s innovative approach to development of anti-cancer compounds has been rewarded with outstanding results … Read more